LYNX-1: A Pivotal Phase 3 Double-Masked, Randomized Placebo-Controlled Trial of Phentolamine Ophthalmic Solution in Subjects with Dim Light Vision Disturbance
Phentolamine Ophthalmic Solution 0.75%
Presented at American Society of Cataract and Refractive Surgery 2023